Activator protein 1 promotes gemcitabine-induced apoptosis in pancreatic cancer by upregulating its downstream target Bim
Xiaoxia Ren(Peking Union Medical College Hospital), Yupei Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 20
Related Papers
LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
|Journal of Experimental & Clinical Cancer Research|2018|141
SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src/PI3K/Akt signaling pathway
|Cell Death and Disease|2023|82
High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis
|Journal of Hematology & Oncology|2021|68
CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration
|Journal of Cancer|2020|56
PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value
|Journal of Experimental & Clinical Cancer Research|2016|52